Gores Group realises 10x return on Therakos
<p>The firm has made a record gain through the $1.3 billion sale of the immunotherapy company to Mallinckrodt.</p> <p> </p>
29 September 2015•1 min read
<p>The firm has made a record gain through the $1.3 billion sale of the immunotherapy company to Mallinckrodt.</p> <p> </p>
